Viewing Study NCT06525259


Ignite Creation Date: 2025-12-24 @ 2:55 PM
Ignite Modification Date: 2025-12-28 @ 1:12 AM
Study NCT ID: NCT06525259
Status: RECRUITING
Last Update Posted: 2025-05-09
First Post: 2024-07-18
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: DISCOVERY of Risk Factors for Type 2 Diabetes in Youth
Sponsor: George Washington University
Organization:

Study Overview

Official Title: DISCOVERY of Risk Factors for Type 2 Diabetes in Youth
Status: RECRUITING
Status Verified Date: 2025-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: DISCOVERY
Brief Summary: The goal of the DISCOVERY study is to provide innovative critical information regarding the unique natural history of glycemic control, insulin sensitivity, and β-cell function, and their mechanistic determinates, in obese adolescents at risk for developing type 2 diabetes.
Detailed Description: The DISCOVERY study will extensively phenotype a large cohort of youth at-risk for type 2 diabetes, as they transition through puberty, and characterize the course of dysfunction in pathophysiological indicators that lead to type 2 diabetes. The knowledge gained from this study of the pathophysiology and epidemiology of youth-onset type 2 diabetes with deep biochemical, clinical, and psychosocial phenotyping will critically inform the design and testing of future treatment and prevention approaches.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?: